RaySearch Laboratories AB (publ) (RAY-B) - Total Assets

Latest as of March 2026: Skr2.03 Billion SEK ≈ $218.20 Million USD

Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) holds total assets worth Skr2.03 Billion SEK (≈ $218.20 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check RAY-B total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

RaySearch Laboratories AB (publ) - Total Assets Trend (2003–2025)

This chart illustrates how RaySearch Laboratories AB (publ)'s total assets have evolved over time, based on quarterly financial data. Check RaySearch Laboratories AB (publ) (RAY-B) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

RaySearch Laboratories AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2025)

RaySearch Laboratories AB (publ)'s total assets of Skr2.03 Billion consist of 48.7% current assets and 51.3% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr407.30 Million 20.5%
Accounts Receivable Skr541.40 Million 27.2%
Inventory Skr22.00 Million 1.1%
Property, Plant & Equipment Skr447.30 Million 22.5%
Intangible Assets Skr558.70 Million 28.1%
Goodwill Skr0.00 0.0%

Asset Composition Trend (2003–2025)

This chart illustrates how RaySearch Laboratories AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RaySearch Laboratories AB (publ) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: RaySearch Laboratories AB (publ)'s current assets represent 48.7% of total assets in 2025, a decrease from 74.1% in 2003.
  • Cash Position: Cash and equivalents constituted 20.5% of total assets in 2025, up from 20.2% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 18.0% in 2003.
  • Asset Diversification: The largest asset category is intangible assets at 28.1% of total assets.

RaySearch Laboratories AB (publ) Competitors by Total Assets

Key competitors of RaySearch Laboratories AB (publ) based on total assets are shown below.

Company Country Total Assets
INVENTURUS KNOWLEDGE SO L
NSE:IKS
India Rs36.06 Billion
Waystar Holding Corp. Common Stock
NASDAQ:WAY
USA $5.84 Billion
DocCheck AG
XETRA:AJ91
Germany €55.68 Million
Kovo Healthtech Corp
V:KOVO
Canada CA$6.64 Million
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
ARTRYA Ltd
AU:AYA
Australia AU$92.19 Million
Cogstate Ltd
AU:CGS
Australia AU$64.77 Million

RaySearch Laboratories AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.79 1.53 1.39
Quick Ratio 1.71 1.52 1.33
Cash Ratio 0.00 0.78 0.38
Working Capital Skr446.20 Million Skr342.77 Million Skr133.02 Million

RaySearch Laboratories AB (publ) - Advanced Valuation Insights

This section examines the relationship between RaySearch Laboratories AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 7.14
Latest Market Cap to Assets Ratio 0.35
Asset Growth Rate (YoY) -4.7%
Total Assets Skr1.99 Billion
Market Capitalization $689.42 Million USD

Valuation Analysis

Below Book Valuation: The market values RaySearch Laboratories AB (publ)'s assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: RaySearch Laboratories AB (publ)'s assets decreased by 4.7% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for RaySearch Laboratories AB (publ) (2003–2025)

The table below shows the annual total assets of RaySearch Laboratories AB (publ) from 2003 to 2025.

Year Total Assets Change
2025-12-31 Skr1.99 Billion
≈ $214.37 Million
-4.74%
2024-12-31 Skr2.09 Billion
≈ $225.04 Million
+7.09%
2023-12-31 Skr1.95 Billion
≈ $210.14 Million
+4.09%
2022-12-31 Skr1.88 Billion
≈ $201.88 Million
+7.87%
2021-12-31 Skr1.74 Billion
≈ $187.15 Million
+35.34%
2020-12-31 Skr1.28 Billion
≈ $138.28 Million
+1.64%
2019-12-31 Skr1.26 Billion
≈ $136.05 Million
+14.37%
2018-12-31 Skr1.11 Billion
≈ $118.96 Million
+20.80%
2017-12-31 Skr915.06 Million
≈ $98.48 Million
+27.58%
2016-12-31 Skr717.25 Million
≈ $77.19 Million
+48.04%
2015-12-31 Skr484.49 Million
≈ $52.14 Million
+24.31%
2014-12-31 Skr389.75 Million
≈ $41.94 Million
+30.28%
2013-12-31 Skr299.16 Million
≈ $32.19 Million
+2.09%
2012-12-31 Skr293.03 Million
≈ $31.53 Million
+12.27%
2011-12-31 Skr261.00 Million
≈ $28.09 Million
+1.98%
2010-12-31 Skr255.93 Million
≈ $27.54 Million
+9.79%
2009-12-31 Skr233.10 Million
≈ $25.09 Million
+23.93%
2008-12-31 Skr188.09 Million
≈ $20.24 Million
+8.58%
2007-12-31 Skr173.23 Million
≈ $18.64 Million
+18.43%
2006-12-31 Skr146.27 Million
≈ $15.74 Million
+36.47%
2005-12-31 Skr107.18 Million
≈ $11.53 Million
+135.99%
2004-12-31 Skr45.42 Million
≈ $4.89 Million
+47.67%
2003-12-31 Skr30.76 Million
≈ $3.31 Million
--

About RaySearch Laboratories AB (publ)

ST:RAY-B Sweden Health Information Services
Market Cap
$689.42 Million
Skr6.41 Billion SEK
Market Cap Rank
#10800 Global
#168 in Sweden
Share Price
Skr208.00
Change (1 day)
-1.14%
52-Week Range
Skr168.40 - Skr365.50
All Time High
Skr365.50
About

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more